Price $65.26 |
Market Cap
3.24B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
73.9
|
P/B
4.25
|
P/S
3.21
|
Dividend %
-
|
|
P/CF
47.7
|
P/FCF
42.3
|
Op. Cash Flow
172.3K
|
FCF
1.4
|
|
Op. Margin
8.10%
|
Net Margin
4.40%
|
ROE
6.10%
|
ROI
4.00%
|
|
ROA
2.40%
|
EPS Growth
-45.90%
|
Current Ratio
1.7
|
Debt/Equity
74.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Biostem Technologies Inc (BSEM) | $1.95 | - | - | 22M | Strong Buy |
| Lannett Company, Inc. (LCI) | $0.58 | - | - | 22.4M | Strong Buy |
| Clearside Biomedical Inc (CLSD) | $1.65 | - | - | 78.2M | Strong Buy |
| Assertio Holdings Inc (ASRT) | $2.73 | - | - | 136.8M | Strong Buy |
| Arbutus Biopharma Corp (ABUS) | $2.84 | - | - | 361.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
